Spago Nanomedical AB (publ)
556574-5048ActiveSwedish nanomedicine company developing precision cancer diagnostics and therapy.
Clinical Stage Nanomedicines Companyspagonanomedical.se
Overview
- 10–19
- Employees
- 2.5–5M SEK
- Revenue
- 1999
- Founded
Key Decision Makers
Mats Hansen
Chief Executive Officer (CEO)
@spagonanomedical.se+46468XXXX
Eva Redhe
Nomination Committee Member
@spagonanomedical.se
Paul Hargreaves
Chief Development Officer (CDO)
@spagonanomedical.se
Alan Raffensperger
Chairman of the Board
@spagonanomedical.se
+11 more contacts in Funnelfeedr
Description
Spago Nanomedical AB is a Swedish company currently operating in the clinical development phase. It specializes in precision nanomedicine, utilizing a proprietary platform based on advanced polymeric materials. The core mission is to create more precise treatments and imaging diagnostics for cancer...
NUCLITHERA AS